Skip to main content

Table 2 Characteristics of the study population, by ethnicity

From: A feasibility study to assess the validity of administrative data sources and self-reported information of breast cancer survivors

Characteristic

Breast cancer patients (n = 83, 100 %)a

Jewish women

(n = 54, 65.1 %)

Arab women

(n = 29, 34.9 %)

Demographics

 Age at breast cancer diagnosis

   ≤ 39 years

2 (3.7)

8 (27.6)

  40–49 years

13 (24.1)

8 (27.6)

  50–59 years

21 (38.9)

8 (27.6)

   ≥ 60 years

18 (33.3)

5 (17.2)

 Cohabitation status

  Married/living with a spouse

27 (50.0)

15 (51.7)

  Unmarriedb

18 (33.3)

7 (24.1)

  Missingc

9 (16.7)

7 (24.1)

  Education, meand (SD), year

13.3 (3.1)

7.2 (4.8)

 Immigration status

  Yes (country birth not Israel)

34 (63.0)

1 (3.4)

  No (country birth Israel)

11 (20.4)

21 (72.4)

  Missing

9 (16.7)

7 (24.1)

 Parity

  0

2 (3.7)

3 (10.3)

  1

12 (22.2)

0 (0.0)

  2

16 (29.6)

2 (6.9)

  3

9 (16.7)

2 (6.9)

   ≥ 4

6 (11.1)

15 (51.7)

  Missing

9 (16.7)

7 (24.1)

Breast cancer treatment and related effects

 Breast cancer diagnosis year

  2003–2005

21 (38.9)

8 (27.6)

  2006–2008

18 (33.3)

12 (41.4)

  2009–2010

15 (27.8)

9 (31.0)

 Treatments

  Breast conserving

41 (75.9)

18 (62.1)

  Mastectomy

12 (22.2)

10 (34.5)

  Axillary lymph node dissection

32 (59.3)

21 (72.4)

  Radiotherapy

48 (88.9)

27 (93.1)

  Chemotherapye

28 (51.9)

23 (79.3)

  Hormone therapyf

41 (75.9)

20 (69.0)

 Employment transition following diagnosis/treatment

  No change

25 (46.3)

17 (58.6)

  Upgraded

1 (1.9)

0 (0.0)

  Downgraded

19 (35.2)

5 (17.2)

  Missing

9 (16.7)

7 (24.1)

 Income change following diagnosis/treatment

  No change

26 (48.2)

17 (58.6)

  Increased

0 (0.0)

1 (3.5)

  Decreased

19 (35.2)

4 (13.8)

  Missing

9 (16.7)

7 (24.1)

 Weight change following diagnosis/treatment

  No change

15 (27.8)

8 (27.6)

  Increased

16 (29.6)

11 (37.9)

  Decreased

13 (24.1)

3 (10.3)

  Don’t know

1 (1.9)

0 (0.0)

  Missing

9 (16.7)

7 (24.1)

 Chronic pain related to breast cancer

  Yes

31 (57.4)

19 (65.5)

  No

14 (25.9)

3 (10.3)

  Missing

9 (16.7)

7 (24.1)

 Chronic pain intensity

  0 (no pain)

14 (25.9)

3 (10.3)

  1–3 (light pain)

5 (9.3)

3 (10.3)

  4–7 (moderate pain)

26 (48.2)

10 (34.5)

  8–10 (severe pain)

0 (0.0)

6 (20.7)

  Missing

9 (16.7)

7 (24.1)

 Number of chronic pain locations

  0

14 (25.9)

3 (10.3)

  1–2

24 (44.4)

9 (31.0)

  3–4

7 (13.0)

10 (34.5)

  Missing

9 (16.7)

7 (24.1)

Lifestyles

 Tobacco use

  Current smoker

7 (13.0)

2 (6.9)

  Former smoker

7 (13.0)

1 (3.5)

  Never smoker

31 (57.4)

19 (65.5)

  Missing

9 (16.7)

7 (24.1)

 Physical activity

  Yes

33 (61.1)

13 (44.8)

  No

12 (22.2)

9 (31.0)

  Missing

9 (16.7)

7 (24.1)

 Daily servings of fruits and vegetables

  0

0 (0.0)

0 (0.0)

  1–2

28 (51.9)

18 (62.1)

   ≥ 3

17 (31.5)

4 (13.8)

  Missing

9 (16.7)

7 (24.1)

  BMI, mean (SD), kg/m2

27.4 (4.9)

29.5 (6.3)

  1. Abbreviations: SD standard deviation, BMI body mass index
  2. a 83 Eligible participants identified by both LHS and INCR records; of them 67 completed the survey questionnaire. Data are presented as No.(%) unless otherwise noted; percentages may not sum to 100 due to rounding
  3. b Unmarried category comprised of all women not married: divorced, separated, widowed, or single
  4. c Missing information refers to information elicited from questionnaires, since not all subjects were interviewed
  5. d Analysis of mean education did not include missing data of 16 subjects who were not interviewed
  6. e Chemotherapy comprised mainly of anthracycline or taxane-based combinations
  7. f Hormone therapy was based on aromatase inhibitors, anti-estrogens, or combinations